Skip to main content
. 2021 Oct 25;11(5):564–575.

Table 2.

Predictors of increased LV filling pressure in patients with HFpEF and AF ± T2DM

Coefficient (β) p-value OR [95% CI]
No T2DM REFERENCE - -
T2DM OAD 1.49 0.0134 4.44 [1.37 to 15.17]
T2DM IR 1.83 0.0102 6.25 [1.50 to 25.98]
T2DM
    No REFERENCE - -
    Yes 1.60 0.0032 5.00 [1.77 to 15.59]
Age 0.02 0.2247 1.02 [0.98 to 1.07]
Sex
    F REFERENCE - -
    M 0.008 0.9880 1.008 [0.32 to 2.85]
Obesity
    No REFERENCE - -
    Yes 0.38 0.4470 1.47 [0.54 to 4.05]
Mitral regurgitation
    No REFERENCE - -
    Yes -0.70 0.2810 0.49 [0.14 to 1.98]
Mitral stenosis
    No REFERENCE - -
    Yes 0.84 0.4990 2.33 [0.10 to 25.65]
Aortic regurgitation
    No REFERENCE - -
    Yes 0.84 0.1040 2.32 [0.83 to 6.48]
Aortic stenosis
    No REFERENCE - -
    Yes 0.58 [0.18 to 1.71]
Hypertension
    No REFERENCE - -
    Yes -0.47 0.5122 0.62 [0.16 to 3.03]
Coronary artery disease
    No REFERENCE - -
    Yes 1.51 0.0043 4.53 [1.62 to 13.26]
Chronic kidney disease
    No REFERENCE - -
    Yes 1.58 0.0032 4.86 [1.70 to 14.24]

Note: OR-odds ratio; CI-confidence interval; T2DM-diabetes mellitus; OAD-oral antidiabetics; IR-insulin-requiring.